Literature DB >> 2293751

High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study.

D R Jacobs1, I L Mebane, S I Bangdiwala, M H Criqui, H A Tyroler.   

Abstract

With data from the Lipid Research Clinics Prevalence Study used as a baseline, an average of 8.4 years of mortality follow-up has been completed for 8,825 male and female participants who were at least 30 years of age at the time of the study. The participants were examined at 10 North American sites during 1972-1976. Univariate findings for high density lipoprotein (HDL) cholesterol in the 7,569 persons initially free of coronary heart disease indicate an inverse relation with cardiovascular disease mortality for men and women. Controlling for age, low density lipoprotein (LDL) cholesterol, triglycerides, body mass index, systolic blood pressure, and smoking, multivariate analysis results indicate inverse relations between HDL cholesterol and cardiovascular disease mortality. In men, the cardiovascular disease mortality rate ratio for HDL cholesterol increments of 10 mg/dl was similar to the cardiovascular disease mortality rate ratio for LDL cholesterol increments of 30 mg/dl. In women, HDL cholesterol is more closely related to cardiovascular disease than is LDL cholesterol. HDL cholesterol is inversely related to both coronary heart disease and other cardiovascular disease mortality in both sexes, though the relation of HDL cholesterol with coronary heart disease mortality in women approached statistical significance only for the combined end point of suspect and definite cases. No relation was observed in either sex group between HDL cholesterol and noncardiovascular disease mortality. This study, only the second large prospective study evaluating the role of HDL cholesterol in women, confirms both the importance and the independence in both men and women of HDL cholesterol in the epidemiology of coronary heart disease and other cardiovascular disease mortality.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2293751     DOI: 10.1093/oxfordjournals.aje.a115483

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  64 in total

1.  Serum opacity factor enhances HDL-mediated cholesterol efflux, esterification and anti inflammatory effects.

Authors:  Urbain Tchoua; Corina Rosales; Daming Tang; Baiba K Gillard; Ashley Vaughan; Hu Yu Lin; Harry S Courtney; Henry J Pownall
Journal:  Lipids       Date:  2010-10-24       Impact factor: 1.880

Review 2.  Comparing HMG-CoA reductase inhibitors.

Authors:  Peter H Jones
Journal:  Clin Cardiol       Date:  2003-01       Impact factor: 2.882

3.  Low fat-monounsaturated rich diets containing high-oleic peanuts improve serum lipoprotein profiles.

Authors:  D J O'Byrne; D A Knauft; R B Shireman
Journal:  Lipids       Date:  1997-07       Impact factor: 1.880

4.  Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors.

Authors:  E B Rimm; P Williams; K Fosher; M Criqui; M J Stampfer
Journal:  BMJ       Date:  1999-12-11

5.  Primary Prevention of Atherosclerotic Cardiovascular Disease in Women.

Authors:  Rebeccah A McKibben; Mahmoud Al Rifai; Lena M Mathews; Erin D Michos
Journal:  Curr Cardiovasc Risk Rep       Date:  2015-12-29

6.  Effects of exposure to carbon disulphide on low density lipoprotein cholesterol concentration and diastolic blood pressure.

Authors:  G M Egeland; G A Burkhart; T M Schnorr; R W Hornung; J M Fajen; S T Lee
Journal:  Br J Ind Med       Date:  1992-04

7.  Plasma lipids and lipoproteins and the prevalence of risk for coronary heart disease in Canadian adults. Canadian Heart Health Surveys Research Group.

Authors:  P W Connelly; D R MacLean; L Horlick; B O'Connor; A Petrasovits; J A Little
Journal:  CMAJ       Date:  1992-06-01       Impact factor: 8.262

8.  Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol.

Authors:  A Inazu; X C Jiang; T Haraki; K Yagi; N Kamon; J Koizumi; H Mabuchi; R Takeda; K Takata; Y Moriyama
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

9.  Prevention of Cardiovascular Disease in Women.

Authors:  Omer L. Shedd; Marian C. Limacher
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-08

10.  Raising HDL cholesterol with low-dose nicotinic acid and bezafibrate: preliminary experience.

Authors:  M H Luria; D Sapoznikov
Journal:  Postgrad Med J       Date:  1993-04       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.